Clinical Trial Update: Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A [Phase 3]

View source ↗

Summary

This report documents the completion and results posting of a Phase 3 pharmacokinetic, efficacy, and safety study evaluating recombinant Factor VIII single chai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hemophilia

Drugs mentioned

• rVIII-SingleChain (Factor VIII, recombinant, single-chain)

Snippet

Sponsor: CSL Behring | Conditions: Congenital Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2017-01-27